Corteva's Share of DuPont's Restructuring Liabilities Comes Under Renewed Legal Scrutiny

Introduction

Corteva's potential responsibility for legacy DuPont liabilities is facing renewed legal scrutiny as California expands its PFAS litigation against companies connected to the former DuPont corporate structure.

On August 6, 2026, California Attorney General Rob Bonta filed a Second Amended Complaint alleging that New DuPont, Corteva, Chemours, and Qnity Electronics used a series of corporate restructuring and asset-transfer arrangements to limit exposure to PFAS liabilities. The allegations remain subject to litigation.

Corteva's Role in the Liability Structure

The dispute is closely connected to the separation of the former DuPont businesses. California's complaint focuses on how PFAS liabilities were allocated among the companies created through the restructuring.

According to an earlier California complaint, the DowDuPont Separation Agreement contemplated allocation of certain PFAS and PFAS Products liabilities between New DuPont and Corteva, with 71% allocated to New DuPont and 29% to Corteva once specified conditions were satisfied.

Corteva's own regulatory disclosures have also described arrangements under which Corteva and DuPont share certain future liabilities, including specific provisions for PFAS-related costs.

California's New Allegations

The latest complaint argues that the corporate restructuring went beyond simply allocating liabilities between successor companies. California alleges that the arrangements were designed to place the overwhelming majority of PFAS liabilities on Chemours while limiting the exposure of Corteva, New DuPont, and Qnity.

The state alleges that these transactions could constitute fraudulent transfers under California law because they allegedly moved valuable assets away from an entity facing potential PFAS claims.

These are allegations made by California and have not been established as facts by a court.

Insurance Proceeds Become a Major Issue

A significant part of the renewed scrutiny involves PFAS-related insurance coverage.

California alleges that in 2025, Chemours transferred 100% of its rights to receive certain PFAS-related insurance proceeds to Corteva and New DuPont in exchange for a lump-sum payment that the state says was worth less than half of the estimated value of those proceeds.

Under the arrangement described by California, Chemours would later receive a 50% share of additional insurance proceeds after Corteva and New DuPont recovered the lump-sum amount and a fee. The state argues that the transaction reduced assets available to potential creditors while Chemours continued to face substantial PFAS obligations.

Why Corteva's Liability Share Matters

The case highlights a broader issue surrounding corporate spin-offs: how should environmental liabilities be divided when a legacy business is separated into multiple independent companies?

Corporate restructuring agreements can establish contractual responsibilities between the parties, but regulators and creditors may still challenge transactions if they believe assets were moved in a way that undermines potential claims.

For Corteva, the issue is particularly important because its connection to the former DuPont structure means historical environmental obligations can continue to create legal and financial exposure even after the corporate separation.

Potential Financial Implications

Renewed scrutiny could have financial implications for companies involved in the former DuPont structure.

Potential areas of concern include:

• PFAS litigation expenses

• Environmental remediation costs

• Insurance proceeds and recovery rights

• Indemnification obligations

• Corporate asset-transfer arrangements

• Financial reserves for contingent liabilities

• Future settlement costs

The ultimate financial impact will depend on how courts interpret the restructuring agreements and the allegations concerning asset transfers.

Broader Impact on Corporate Restructuring

The California case could have implications beyond Corteva and DuPont.

Companies in chemical, pharmaceutical, energy, and other industries frequently use spin-offs, mergers, divestitures, and internal reorganizations to separate business operations. When those businesses carry significant environmental or product liabilities, the allocation of responsibility can become a major legal consideration.

The case therefore demonstrates why companies may need to conduct detailed assessments of historical liabilities before transferring assets or separating business units.

PFAS Liability Continues to Expand

The dispute comes amid broader expansion of PFAS litigation in the United States. California's lawsuit seeks remedies related to alleged PFAS contamination, including treatment of affected water, environmental testing, medical monitoring, replacement water, and other measures.

The state's amended complaint also seeks to prevent certain companies from distributing or transferring proceeds from the sale of businesses or assets that formerly belonged to Old DuPont, or alternatively to impose a constructive trust over those proceeds.

This indicates that PFAS litigation is increasingly examining not only environmental contamination itself but also the corporate structures through which historical liabilities are managed.

Implications for Investors and Industry Stakeholders

For investors, the case illustrates why legacy liabilities can remain relevant when evaluating companies created through major corporate restructurings.

A business may appear legally independent from its predecessor, while contractual indemnities, liability-sharing arrangements, insurance rights, or historical operations can continue to connect the entities.

For chemical companies considering future spin-offs, the developments could reinforce the importance of transparent liability allocation, adequate financial protections, and careful documentation of asset transfers.

Looking Ahead

The California litigation will provide an important test of how courts treat liability-sharing agreements and asset transfers within complex corporate restructurings.

For Corteva, the central issue is not simply the percentage of liabilities allocated under historical agreements, but whether those arrangements and subsequent transactions can withstand challenges from government authorities and potential creditors.

The outcome could influence future approaches to environmental liability management, particularly for companies separating businesses with substantial legacy chemical exposures.

Conclusion

Corteva's share of DuPont's restructuring liabilities is coming under renewed legal scrutiny as California challenges the way PFAS obligations and assets were allocated among DuPont-related companies.

The state's allegations focus on whether corporate restructuring and subsequent asset transfers improperly limited the resources available to satisfy PFAS claims. Corteva and the other defendants will have the opportunity to contest these allegations through the legal process.

More broadly, the case underscores a growing principle in environmental litigation: corporate restructuring can redistribute contractual responsibilities, but it may not prevent regulators and creditors from examining whether those arrangements leave sufficient assets available to address legacy liabilities.